• Medientyp: E-Artikel
  • Titel: Is it possible to achieve an acceptable disease control by dietary therapy alone in Berardinelli Seip type 1? Experience from a case report
  • Beteiligte: Cecchetti, Carolina; Belardinelli, Elisabetta; Dionese, Paola; Teglia, Rita; Fazzeri, Roberta; D’ Apice, M. Rosaria; Vestito, Amanda; Pagotto, Uberto; Gambineri, Alessandra
  • Erschienen: Frontiers Media SA, 2023
  • Erschienen in: Frontiers in Endocrinology
  • Sprache: Nicht zu entscheiden
  • DOI: 10.3389/fendo.2023.1190363
  • ISSN: 1664-2392
  • Schlagwörter: Endocrinology, Diabetes and Metabolism
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:sec><jats:title>Background and objective</jats:title><jats:p>Severe metabolic complications generally manifest at an early age in Berardinelli – Seip congenital lipodystrophy (BSCL) and their management is especially challenging. Nutritional intervention with low lipid diets is considered by experts to be fundamental in treating the disease when associated with medical therapy, however little is known about the beneficial effects of dietary interventions alone.</jats:p></jats:sec><jats:sec><jats:title>Aim</jats:title><jats:p>To underline the importance of a well-structured low-fat diet in BSCL patients.</jats:p></jats:sec><jats:sec><jats:title>Methods and results</jats:title><jats:p>A BSCL male patient strictly followed a hypocaloric hypolipemic diet (60% carbohydrates, 22% fats and 18% proteins) since clinical diagnosis at the age of one year. Interestingly, pharmacological interventions were not required at any point during the follow-up. Aged 16 years the patient was referred to our center. Biochemistry, hormonal evaluation, 75 mg oral glucose tolerance test, cardiac evaluation and abdominal ultrasound were performed, revealing no abnormalities. Genetic analysis and leptin dosage were carried out, confirming the diagnosis of BSCL type 1 (homozygosity for c.493-1G&amp;gt;C pathogenic variant in <jats:italic>AGPAT2</jats:italic> gene) and showing undetectable circulating levels of leptin (&amp;lt; 0.2 mcg/L). Diet therapy alone was therefore maintained, scheduling follow-up visits every six months, with acceptable disease control ever since.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>This report proves how a low-fat diet is of great help in the management of BSCL and its complications. In addition, a specific hypolipemic diet could be used alone as an effective treatment in selected cases with high compliance and, probably, a milder phenotype.</jats:p></jats:sec>
  • Zugangsstatus: Freier Zugang